Enliven Therapeutics Inc
NASDAQ:ELVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Enliven Therapeutics Inc
NASDAQ:ELVN
|
US |
|
Paragon Shipping Inc
OTC:PRGNF
|
GR |
|
Radiopharm Theranostics Ltd
NASDAQ:RADX
|
AU |
|
Adx Energy Ltd
ASX:ADX
|
AU |
|
Greatview Aseptic Packaging Co Ltd
F:8GA
|
CN |
|
P
|
PLB Engineering Bhd
KLSE:PLB
|
MY |
|
T
|
Trifecta Gold Ltd
OTC:TRRFF
|
CA |
|
PHSC PLC
LSE:PHSC
|
UK |
|
J
|
JRC Co Ltd
TSE:6224
|
JP |
|
F
|
Flying Nickel Mining Corp
XTSX:FLYN
|
CA |
|
J
|
Justem Co Ltd
KOSDAQ:417840
|
KR |
|
P
|
Petrus Resources Ltd
OTC:PTRUF
|
CA |
|
Cynata Therapeutics Ltd
F:51S
|
AU |
|
N
|
Nano Chem Tech Inc
KOSDAQ:091970
|
KR |
|
C
|
China Rare Earth Holdings Ltd
F:RAE
|
CN |
|
Energiedienst Holding AG
F:KWK3
|
CH |
|
Wegener Corp
OTC:WGNR
|
US |
|
J
|
Jumbo Interactive Ltd
F:JUB
|
AU |
|
3
|
3Billion Inc
KOSDAQ:394800
|
KR |
|
Redwood Financial Services Inc
OTC:REDW
|
US |
|
Tectonic Metals Inc
XTSX:TECT
|
CA |
|
Redacted Industries Inc
OTC:RDCT
|
US |
|
Integra Resources Corp
XTSX:ITR
|
CA |
|
Apollo Finvest (India) Ltd
BSE:512437
|
IN |
Wall St Price Targets
ELVN Price Targets Summary
Enliven Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ELVN is 74.92 USD with a low forecast of 65.65 USD and a high forecast of 86.1 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELVN's stock price target?
Price Target
74.92
USD
According to Wall Street analysts, the average 1-year price target for
ELVN is 74.92 USD with a low forecast of 65.65 USD and a high forecast of 86.1 USD.